These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 581603

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Structure-activity relationship of tuftsin, a phagocytosis-stimulating peptide, and its analogs.
    Hisatsune K, Kobayashi K, Nozaki S, Muramatsu I.
    Chem Pharm Bull (Tokyo); 1978 Mar; 26(3):1006-7. PubMed ID: 580599
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Does tuftsin alter phagocytosis by human polymorphonuclear neutrophils?
    Cooper MR, DeChatelet LR, Shirley PS, Cooper MR.
    Inflammation; 1982 Mar; 6(1):103-12. PubMed ID: 6896319
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Tuftsin--new analogues and properties].
    Wardowska A, Dzierzbicka K, Myśliwski A.
    Postepy Biochem; 2007 Mar; 53(1):60-5. PubMed ID: 17718389
    [Abstract] [Full Text] [Related]

  • 9. The effects of met-enkephaline, leu-enkephaline and tuftsine on guinea pig peritoneal granulocyte functions in vitro.
    Godlewski A, Brzeziński PM.
    Folia Morphol (Warsz); 1996 Mar; 55(4):251-2. PubMed ID: 9243868
    [No Abstract] [Full Text] [Related]

  • 10. Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.
    Tzehoval E, Segal S, Stabinsky Y, Fridkin M, Spirer Z, Feldman M.
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3400-4. PubMed ID: 277940
    [Abstract] [Full Text] [Related]

  • 11. On the mechanism of action of the phagocytosis-stimulating peptide tuftsin.
    Stabinsky Y, Bar-Shavit Z, Fridkin M, Goldman R.
    Mol Cell Biochem; 1980 Apr 18; 30(2):71-7. PubMed ID: 6247642
    [Abstract] [Full Text] [Related]

  • 12. Tuftsin analogs and their biological activity.
    Siemion IZ, Konopinska D.
    Mol Cell Biochem; 1981 Dec 04; 41():99-112. PubMed ID: 6799778
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tuftsin and substance P as modulators of phagocyte functions.
    Bar-Shavit Z, Goldman R.
    Adv Exp Med Biol; 1982 Dec 04; 141():549-58. PubMed ID: 6178274
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Peptide fragments from the tuftsin containing domain of immunoglobulin G synthesis and biological activity.
    Gottlieb P, Tzehoval E, Feldman M, Segal S, Fridkin M.
    Biochem Biophys Res Commun; 1983 Aug 30; 115(1):193-200. PubMed ID: 6311202
    [Abstract] [Full Text] [Related]

  • 18. Partial sequences of histones with tuftsin activity.
    Konopínska D, Nawrocka E, Siemion IZ, Slopek S, Szymaniec S, Klonowska E.
    Int J Pept Protein Res; 1977 Jan 30; 9(1):71-7. PubMed ID: 576424
    [No Abstract] [Full Text] [Related]

  • 19. Competition between tuftsin and HIV-1, HIV-2 envelope protein sequences.
    Siemion IZ, Słoń J, Wieczorek Z.
    Arch Immunol Ther Exp (Warsz); 1991 Jan 30; 39(5-6):469-78. PubMed ID: 1841544
    [Abstract] [Full Text] [Related]

  • 20. Inhibition by tuftsin of Rauscher virus leukemia development in mice.
    Knyszynski A, Gottlieb P, Fridkin M.
    J Natl Cancer Inst; 1983 Jul 30; 71(1):87-90. PubMed ID: 6575215
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.